CLSN - Imunon Inc
Previous close
1.96
0 0%
Share volume: 0
Last Updated: Tue 20 Sep 2022 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$1.96
0.00
0.00%
Summary score
10%
Profitability
0%
Dept financing
10%
Liquidity
55%
Performance
10%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2018 - 30-Jun-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.96%
Return on assets
-10.06%
Return on sales
-4178.09%
Return on invested capital
-35.52%
Total debt ratio
44.54%
Debt ratio change over timeo
-2.13%
Current Ratio
5.12%
Quick Ratio
6.95%
Cash Position Ratio
3.89%
Short-term ratios 30-Jun-2021 - 30-Jun-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.04%
Return on assets
-8%
Return on sales
-4474.54%
Return on invested capital
-45.33%
Total debt ratio
26.51%
Debt ratio change over timeo
-1.66%
Current Ratio
7.39%
Quick Ratio
7.39%
Cash Position Ratio
7.01%
Last quarter ratios 30-Jun-2022
The data are presented for the financials results of the last quarter.
Return on equity
-12.85%
Return on assets
-9.15%
Return on sales
-4782.62%
Return on invested capital
-44.68%
Total debt ratio
27.99%
Debt ratio change over time
-1.63%
Current Ratio
6.52%
Quick Ratio
6.52%
Cash Position Ratio
6.11%
Performance ratios (change over 4 years) 30-Jun-2018 - 30-Jun-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-50.86%
Return on assets
-74%
Return on sales
10955.31%
Return on invested capital
-3.53%
Total debt ratio
-213.34%
Debt ratio change over time
-2.13%
Current Ratio
-14.8%
Quick Ratio
-20.84%
Cash Position Ratio
-12.02%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CLSN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -17.96% | 0% | 0% | 5.53% |
| Return on assets | -10.06% | 0% | 0% | -10.09% |
| Return on sales | -4178.09% | 0% | 0% | -3350.54% |
| Return on invested capital | -35.52% | 0% | 0% | 48.22% |
| Profitability | 0% | 0% | 50% | 50% |
| Total debt ratio | 44.54% | 0% | 0% | 78.89% |
| Debt ratio change over time | -2.13% | 0% | 0% | -0.16% |
| Dept financing | 14% | 0% | 25% | 25% |
| Current Ratio | 7.39% | 0% | 0% | 9.98% |
| Quick Ratio | 7.39% | 0% | 0% | 9.98% |
| Cash Position Ratio | 7.01% | 0% | 0% | 9.85% |
| Liquididy | 54% | 0% | 0% | 75% |
| Short-term ratios | CLSN | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -13.04% | 0% | 0% | -59.73% |
| Return on assets | -8% | 0% | 0% | -9.31% |
| Return on sales | -4474.54% | 0% | 0% | -5963.02% |
| Return on invested capital | -45.33% | 0% | 0% | -47.3% |
| Profitability | 0% | 0% | 100% | 0% |
| Total debt ratio | 26.51% | 0% | 0% | 77.51% |
| Debt ratio change over time | -1.66% | 0% | 0% | -1.49% |
| Dept financing | 9% | 0% | 25% | 25% |
| Current Ratio | 7.39% | 0% | 0% | 9.98% |
| Quick Ratio | 7.39% | 0% | 0% | 9.98% |
| Cash Position Ratio | 7.01% | 0% | 0% | 9.85% |
| Liquididy | 55% | 0% | 0% | 75% |